Login / Signup
Ilse Van Vlaenderen
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Public Health
Young Adults
Decision Making
Top Venues
Human vaccines & immunotherapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Daniel Molnar
,
Anastassia Anastassopoulou
,
Barbara Poulsen Nautrup
,
Ruprecht Schmidt-Ott
,
Martin Eichner
,
Markus Schwehm
,
Gaël Dos Santos
,
Bernhard Ultsch
,
Rafik Bekkat-Berkani
,
Alfred von Krempelhuber
,
Ilse Van Vlaenderen
,
Laure-Anne Van Bellinghen
Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany.
Human vaccines & immunotherapeutics
18 (5) (2022)